Highbridge Capital Management LLC Amryt Pharma PLC Transaction History

Highbridge Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 14, 2023	BUY	$7.0 - $14.77 $44.3 Million - $93.5 Million	6,333,552 New	6,333,552 $92.3 Million
Q2 2022 Aug 11, 2022	BUY	$6.85 - $8.87 $1.87 Million - $2.43 Million	273,552 Added 4.51%	6,333,552 $44.3 Million
Q1 2022 May 11, 2022	BUY	$6.3 - $10.86 $26.5 Million - $45.6 Million	4,198,474 Added 225.54%	6,060,000 $50.1 Million
Q4 2021 Feb 11, 2022	BUY	$9.44 - $12.24 $2.14 Million - $2.78 Million	227,160 Added 13.9%	1,861,526 $20.1 Million
Q3 2021 Nov 12, 2021	BUY	$9.63 - $12.47 $9.25 Million - $12 Million	960,965 Added 142.7%	1,634,366 $19.8 Million
Q2 2021 Aug 12, 2021	SELL	$10.9 - $14.29 $3.7 Million - $4.84 Million	-339,023 Reduced 33.49%	673,401 $8.17 Million
Q1 2021 May 12, 2021	BUY	$13.04 - $14.75 $2.43 Million - $2.74 Million	185,994 Added 22.51%	1,012,424 $14.1 Million
Q4 2020 Feb 12, 2021	BUY	$12.22 - $14.16 $1.84 Million - $2.13 Million	150,396 Added 22.25%	826,430 $11.7 Million
Q3 2020 Nov 12, 2020	BUY	$10.8 - $13.5 $7.3 Million - $9.13 Million	676,034 New	676,034 $8.28 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.